livehealth.store

Vitruvias Therapeutics recalls

Vitruvias Therapeutics has 1 recall on record with the FDA and USDA, the earliest in 2026 and the latest reported on 23 Sep 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls1since 2026

Last 12 months1reported

Class I1100% of total

Ongoing1latest 23 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 1 0

Severity split

Class I 1 100%Class II 0 0%Class III 0 0%

Why vitruvias therapeutics is recalled

Potency & Assay1100%

Product types

Thyroid Medication1100%

By year

20261100%

Ongoing vitruvias therapeutics recalls

1 active

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS I	Thyroid Tablets, USP, 1/2 Grain (30 mg) recalledThyroid	Vitruvias Therapeutics	Potency & Assay	Nationwide

All vitruvias therapeutics recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS I	Thyroid Tablets, USP, 1/2 Grain (30 mg) recalledThyroid	Vitruvias Therapeutics	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.